RIPK1 and breast cancer: Two siRNAs were used to successfully knock down RIPK1 in BC cells (Figure 2(a), left), which found that silencing of RIPK1 markedly reduced cell death caused by SBP-0636457/Dox/z.VAD in BC cells (Figure 2(b)).